David H. Crean to Address Current Capital Raising Issues and Strategies for Biotech Companies to the Association of Corporate Counsel Life Sciences Roundtable

Posted February 03, 2017 by admin | Post a Comment

 

San Diego, CA- February 3, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will be a guest panelist speaker at Association of Corporate Counsel (ACC) of San Diego on March 2, 2017 from 5:00-6:30 PM. Dr. Crean will be joined by fellow panelists Dennis Doucette, Partner, Corporate & Securities, Practice Group Leader for Procopio, and David Szekeres, Senior Vice President, Business Development, General Counsel and Corporate Secretary for Heron Therapeutics, Inc. The panel will address Current Capital Raising Issues and Strategies for Biotech Companies. The event will be held at the offices of Procopio, Cory, Hargreaves & Savitch LLP, 12544 High Bluff Drive, Suite 300, San Diego, CA 92130.

(more…)

Association Corporate Counsel, Capital Raising, Licensing, Pharmaceutical, Biotech, Dennis Doucette, objective capital partners, Partnering, Procopio, Uncategorized

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com